Format

Send to

Choose Destination
Biotechnol Healthc. 2012 Spring;9(1):24-7.

Innovation and Competition: Will Biosimilars Succeed?: The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safety.

Abstract

Biosimilars are here, but there's no clear pathway yet for their approval. Difficult realities about their effect on drug prices, innovation, and competition need to be faced.

PMID:
22606078
PMCID:
PMC3351893

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center